share_log

Adamas One Corp. (NASDAQ:JEWL) CEO Buys $106,800.00 in Stock

Adamas One Corp. (NASDAQ:JEWL) CEO Buys $106,800.00 in Stock

Adamas One Corp.(纳斯达克股票代码:JEWL)首席执行官购买了106,800.00美元的股票
Financial News Live ·  2023/01/26 04:16

Adamas One Corp. (NASDAQ:JEWL – Get Rating) CEO John Grdina acquired 40,000 shares of Adamas One stock in a transaction that occurred on Monday, January 23rd. The shares were purchased at an average cost of $2.67 per share, for a total transaction of $106,800.00. Following the purchase, the chief executive officer now directly owns 6,739,458 shares in the company, valued at $17,994,352.86. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Adamas One Corp.(纳斯达克股票代码:JEWL — Get Rating)首席执行官约翰·格尔迪纳在1月23日星期一进行的一笔交易中收购了4万股Adamas One股票。这些股票的平均购买成本为每股2.67美元,总交易额为106,800.00美元。收购后,首席执行官现在直接拥有该公司的6,739,458股股票,价值17,994,352.86美元。此次收购是在向美国证券交易委员会提交的法律文件中披露的,该文件可通过以下方式获得 这个链接

Adamas One Price Performance

Adamas One 价格表现

Adamas One stock traded up $0.10 during midday trading on Wednesday, hitting $2.65. 79,445 shares of the stock were exchanged, compared to its average volume of 114,972. Adamas One Corp. has a 52 week low of $2.25 and a 52 week high of $11.94.

Adamas One股票在周三午盘交易中上涨0.10美元,达到2.65美元。该股交易了79,445股,而平均交易量为114,972股。Adamas One Corp. 创下52周低点2.25美元,52周高点为11.94美元。

Get
获取
Adamas One
阿达玛斯一号
alerts:
警报:

About Adamas One

关于 Adamas One

(Get Rating)

(获取评分)

Adamas One Corp., a diamond company, produces single crystal diamonds and diamond materials for diamond jewelry industry and industrial markets in the United States and internationally. The company was incorporated in 2018 and is headquartered in Scottsdale, Arizona.
Adamas One Corp. 是一家钻石公司,为美国和国际的钻石珠宝行业和工业市场生产单晶钻石和钻石材料。该公司成立于2018年,总部位于亚利桑那州斯科茨代尔。

Read More

阅读更多

  • Get a free copy of the StockNews.com research report on Adamas One (JEWL)
  • Is The Bottom In For Cyber-Security Stocks?
  • Union Pacific, Norfolk Southern Pull into Buying Zone
  • Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
  • How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
  • Is the Pain Over for Baudax Bio Investors after a 70% Spike?
  • 免费获取 StockNews.com 关于 Adamas One 的研究报告 (JEWL)
  • 网络安全股票触底了吗?
  • 联合太平洋、诺福克南方航空进入买入区
  • Pliant Therapeutics 的差距上涨了 34%:还有更多上行空间?
  • 2023 年初的裁员将如何影响这5只生物技术股?
  • 在飙升70%之后,Baudax Bio投资者的痛苦结束了吗?

Receive News & Ratings for Adamas One Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adamas One and related companies with MarketBeat.com's FREE daily email newsletter.

每天接收 Adamas One 的新闻和评级 -在下面输入您的电子邮件地址,通过Marketbeat.com的免费每日电子邮件时事通讯接收Adamas One及相关公司的最新新闻和分析师评级的简明每日摘要。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发